Table 1. Results of meta-analysis for CCL3L1 CNV and HIV-1 susceptibility.
Study groups | GCN ≤ PMN Vs.GCN > PMN | GCN < PMN Vs.GCN ≥ PMN | ||||
Na | OR (95% CI) | P | Na | OR (95% CI) | P | |
Ethnicity | ||||||
African | 4 | 1.44 (0.87–2.40) | 0.016 | 5 | 1.35 (0.83–2.20) | 0.000 |
Caucasian | 6 | 1.08 (0.76–1.53) | 0.001 | 5 | 1.73 (1.09–2.75) | 0.000 |
Japanese | 1 | 2.92 (1.69–5.07) | − | 1 | 3.50 (2.10–5.86) | − |
Sample size | ||||||
<500 subjects | 8 | 1.35 (0.81–2.25) | 0.000 | 8 | 1.58 (1.00–2.50) | 0.000 |
>500 subjects | 5 | 1.38 (1.00–1.92) | 0.000 | 4 | 1.94 (1.48–2.55) | 0.011 |
Age group | ||||||
Infants | 4 | 2.01 (1.58–2.56) | 0.274 | 4 | 2.10 (1.68–2.63) | 0.994 |
Adults | 9 | 1.19 (0.86–1.65) | 0.000 | 8 | 1.55 (1.05–2.28) | 0.000 |
Number of comparisons.